Neuroinflammation in Post-Traumatic Stress Disorder.
Dong-Hun LeeJi-Young LeeDong-Yong HongEun-Chae LeeSang-Won ParkMan-Ryul LeeJae-Sang OhPublished in: Biomedicines (2022)
Post-traumatic stress disorder (PTSD) is a well-known mental illness, which is caused by various stressors, including memories of past physical assaults and psychological pressure. It is diagnosed as a mental and behavioral disorder, but increasing evidence is linking it to the immune system and inflammatory response. Studies on the relationship between inflammation and PTSD revealed that patients with PTSD had increased levels of inflammatory cytokine biomarkers, such as interleukin-1, interleukin-6, tumor necrosis factor-α, nuclear factor-κB, and C-reactive protein, compared with healthy controls. In addition, animal model experiments imitating PTSD patients suggested the role of inflammation in the pathogenesis and pathophysiology of PTSD. In this review, we summarize the definition of PTSD and its association with increased inflammation, its mechanisms, and future predictable diseases and treatment possibilities. We also discuss anti-inflammatory treatments to address inflammation in PTSD.
Keyphrases
- posttraumatic stress disorder
- social support
- oxidative stress
- mental illness
- inflammatory response
- nuclear factor
- mental health
- depressive symptoms
- toll like receptor
- anti inflammatory
- lipopolysaccharide induced
- ejection fraction
- rheumatoid arthritis
- end stage renal disease
- physical activity
- immune response
- prognostic factors
- lps induced
- single cell
- combination therapy
- subarachnoid hemorrhage
- blood brain barrier